Donawho et al. used a BRCA1-deleted and a BRCA2-mutated MX-1 breast carcinoma xenograft mouse model to perform the in vivo evaluation of the Abbott Cancer Research PARPi, ABT-888. This evidence concerns the gene BRCA1 and cancer.